WYNZORA is a topical medication formulated for the treatment of plaque psoriasis, a chronic autoimmune skin condition characterized by the rapid buildup of skin cells leading to scaling on the skin's surface. It is a unique combination of calcipotriene, a vitamin D analog that helps to regulate skin cell production, and betamethasone dipropionate, a potent corticosteroid that reduces inflammation, itching, and redness. This dual-action cream or ointment is designed for ease of use and aims to provide effective relief from the symptoms of plaque psoriasis, improving the quality of life for those affected by this condition. WYNZORA is typically prescribed by healthcare professionals and should be used according to their directions to ensure safety and efficacy.